Halted Cancer Drug Trials May Harm Patients: Study

Law360, New York (April 10, 2008, 12:00 AM EDT) -- Pharmaceutical companies are increasingly putting the brakes on clinical trials of new cancer drugs once good results are achieved but before possible side effects are identified, a new study has found.

The study, published Wednesday in the medical journal Annals of Oncology, determined that early termination of such trials was on the rise. Only a very small percentage of trials were stopped early due to serious adverse events.

A team of researchers led by Dr. Giovanni Apolone of the Mario Negri Institute for Pharmacological Research in...
To view the full article, register now.